General Western Blot Reagents
Abcam Human Histone H4 peptide, 1MG
Human Histone H4 peptide is a Synthetic blocking peptide. >90% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: H4/A, H4FA, HIST1H4A, H4C2, H4/I, H4FI, HIST1H4B, H4C3, H4/G, H4FG, HIST1H4C, H4C4, H4/B, H4FB, HIST1H4D, H4C5, H4/J, H4FJ, HIST1H4E, H4C6, H4/C, H4FC, HIST1H4F, H4C8, H4/H, H4FH, HIST1H4H, H4C9, H4/M, H4FM, HIST1H4I, H4C11, H4/E, H4FE, HIST1H4J, H4C12, H4/D, H4FD, HIST1H4K, H4C13, H4/K, H4FK, HIST1H4L, H4C14, H4/N, H4F2, H4FN, HIST2H4, HIST2H4A, H4C15, H4/O, H4FO, HIST2H4B, H4C16, H4-16, HIST4H4, H4C1, Histone H4, H4K8cr
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 399885 hydrochloride, 5-HT6 antagonist, 50MG
MW 482.8 Da, Purity >99%. Potent, selective competitive 5-HT6 antagonist (pKi values are 8.81 and 9.02 for rat and human native receptors, respectively). Orally active, cognitive enhancer *in vivo*. Displays >200-fold selectivity over 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT4, 5-HT7, α1B, D2, D3, D4 receptors, ion channels and a range of enzymes.
The product is subject to the following: Abcam Restricted Use Statement
Abcam HENECA, A2A receptor agonist, 10MG
MW 388.4 Da, Purity >99%. Selective A2A receptor agonist (Ki = 2.2 nM). Shows good selectivity for A2A over A1 receptors. Displays antiaggregatory activity. Increases cAMP accumulation (EC50 = 43 nM) and inhibits superoxide anion production (EC50 = 3.63 nM) in neutrophils.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Anisomycin, Protein synthesis inhibitor, 10MG
MW 265.3 Da, Purity >98%. Translational inhibitor of protein synthesis. Highly potent activator of kinase cascades. Potently activates stress-activated protein kinases, p38, JNK MAP and other kinases.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Clioquinol, Metal chelator and ionophore, 1G
MW 305.5 Da, Purity >97%. Metal chelator and ionophore with beneficial effects in animal models of neurodegenerative diseases (Alzheimer's, Parkinson's and Huntington's disease). Effects on Alzheimer's disease attributed to copper and zinc chelation or increased level of a metalloprotease. Other actions reported including iron chelation, inhibition of Huntington expression from its mRNA, proteasome inhibition when complexed with copper, and stimulation of tumor necrosis factor-α secretion. Also inhibitor of CLK-1/MCLK1 (an aging-associated protein).
The product is subject to the following: Abcam Restricted Use Statement
Abcam KDM5/JARID Activity Quantification Assay Kit (Fluorometric).
KDM5/JARID Activity Quantification Assay Kit (Fluorometric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Olanzapine, 5-HT, dopamine, histamine and muscarinic antagonist, 50MG
MW 312.43 g/mol, Purity >99%. 5-HT and D₂ antagonist (Ki values are 4 (5-HT₂A), 11 (5-HT₂C) and 57 (5-HT₃), 31 (D₁), 11 (D₂) and 27 nM (D₄)). Additionally, displays activity at: M₁, M₂, M₃, M₄, H₁, α₁ and α₂ receptors (Ki are 1.9 at (M₁), 18 (M₂), 25 (M₃), 13 (M₄), 19 (α₁) and 7 nM (α₂)). Atypical antipsychotic. Displays anxiolytic activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Herpes Simplex Virus type 1, 200UL
Herpes Simplex Virus type 1 is a Human alphaherpesvirus 1 strain 17 protein, expressed in Native and with >80% purity.
Protein/ Peptide/ Enzyme Synonyms: UL10, gM, Envelope glycoprotein M
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dimaprit dihydrochloride, H2 agonist, 100MG
MW 234.19 Da. Selective H2 agonist. Some selectivity for H3. Does not readily cross the blood-brain barrier. Systemically active following oral administration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nociceptin (1-7) (Orphanin FQ (1-7)), Endogenous ligand for ORL1, 1MG
MW 655.71 g/mol, Purity >95%. Bioactive fragment of nociceptin. ORL₁ (NOP) receptor agonist. Reduces nociception induced hyperalgesia and displays antinociceptive activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam KN-62, CaM kinase II inhibitor. P2 x 7 antagonist., 5MG
MW 721.8 Da, Purity >98%. Cell-permeable, reversible and selective inhibitor of CaM kinase II (IC50 = 500 nM). Interacts with the calmodulin binding site of the enzyme. At higher concentrations reported to inhibit GSK3β, PRAK and MAPKAP-K2. Also potent non-competitive antagonist at the P2X7 receptor (IC50 = 15 nM).
The product is subject to the following: Abcam Restricted Use Statement
Abcam HA-1077 (Fasudil), ROCK2 inhibitor, 10MG
MW 327.8 Da, Purity >98%. ROCK2 inhibitor (IC₅₀ = 1.9 μM). Also shown to inhibit PRK2 (IC₅₀ = 4 μM), MSK1 (IC₅₀ = 5 μM), Rsk2 (IC₅₀ = 15 μM), PKA, p70 S6 Kinase, CaM Kinase and MLCK. Calcium antagonist and vasodilator.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Meropenem trihydrate, beta-lactam antibiotic, 10MG
MW 437.51 g/mol, Purity >98%. Broad-spectrum β-lactam antibiotic. Blood-brain barrier permeable. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-Bisoprolol hemifumarate, beta1 antagonist, 10MG
MW 383.48 g/mol, Purity >99%. Selective β₁ antagonist (Ki = 22.4 nM). Antihypertensive agent.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SBD-F (7-Fluorobenzofurazan-4-sulfonic acid ammonium salt), Fluorescent thiol indicator, 250MG
MW 235.2 Da, Purity >98%. Fluorescent thiol indicator. Reacts with sulfhydryl groups to produce highly fluorescent compounds. Attains low detection limits.
The product is subject to the following: Abcam Restricted Use Statement